Description: This guest symposium sponsored by the Infectious Diseases Society of America and the Association for Molecular Pathology will provide insight into how infectious diseases (ID) clinicians fit into the continuum of care while educating the attendees as to the role molecular pathology plays, through the lens of the ID clinician, in treating patients with infectious diseases. Two practicing infectious diseases physicians and a pharmacist with countless years of combined experience will provide information on multiplex molecular testing, discuss the value of a molecular test from the ID clinicians’ point of view and educate participants on the role rapid diagnostic tests play in antimicrobial stewardship.
Registration: Pre-Registration for this event is now closed. On-Site registration will be available.
Registration Fee: $49 for attendees and $129 non-attendees.
Reaction to and Understanding of Multiplex Molecular Testing
Thomas M. File, Jr. MD MSc MACP FIDSA FCCP
Summa Health, Akron, OH, USA; Northeast Ohio Medical University (NEOMED) Rootstown, OH, USA
President-Elect Infectious Diseases Society of America
Value of Molecular Testing from the Perspective of an ID Physician: When its Useful and When it Isn’t
Maricar Malinis, MD FACP, FIDSA, FAST
Yale School of Medicine, New Haven, CT, USA
The Impact of Rapid Diagnostic Tests with Antimicrobial Stewardship on Patient Care
Debra Goff PharmD, FCCP, FIDSA
Associate Professor, Infectious Diseases Specialist
The Ohio State University Wexner Medical CenterColumbus, OH, USA